ATE510906T1 - Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns - Google Patents

Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns

Info

Publication number
ATE510906T1
ATE510906T1 AT01926989T AT01926989T ATE510906T1 AT E510906 T1 ATE510906 T1 AT E510906T1 AT 01926989 T AT01926989 T AT 01926989T AT 01926989 T AT01926989 T AT 01926989T AT E510906 T1 ATE510906 T1 AT E510906T1
Authority
AT
Austria
Prior art keywords
potassium channel
human brain
new potential
dependent potassium
members
Prior art date
Application number
AT01926989T
Other languages
English (en)
Inventor
Timothy Jegla
Original Assignee
Icagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icagen Inc filed Critical Icagen Inc
Application granted granted Critical
Publication of ATE510906T1 publication Critical patent/ATE510906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01926989T 2000-04-14 2001-04-13 Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns ATE510906T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19779300P 2000-04-14 2000-04-14
US09/833,466 US6727353B2 (en) 2000-04-14 2001-04-11 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain
PCT/US2001/012185 WO2001079455A1 (en) 2000-04-14 2001-04-13 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN

Publications (1)

Publication Number Publication Date
ATE510906T1 true ATE510906T1 (de) 2011-06-15

Family

ID=26893173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926989T ATE510906T1 (de) 2000-04-14 2001-04-13 Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns

Country Status (7)

Country Link
US (2) US6727353B2 (de)
EP (1) EP1183330B1 (de)
JP (1) JP2003530849A (de)
AT (1) ATE510906T1 (de)
AU (1) AU780103B2 (de)
CA (1) CA2370572A1 (de)
WO (1) WO2001079455A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010389A2 (en) * 2000-07-28 2002-02-07 Lexicon Genetics Incorporated Human ion channel proteins and polynucleotides encoding the same
MXPA03003784A (es) * 2000-11-02 2004-04-20 Bristol Myers Squibb Co Polinucleotido que codifica una subunidad alfa del canal de potasio humano novedoso, k+alfa m1, y variantes del mismo.
WO2002055556A2 (en) * 2001-01-12 2002-07-18 Bayer Ag Regulation of human voltage gated potassium channel protein kv2.2
US7027418B2 (en) 2001-01-25 2006-04-11 Bandspeed, Inc. Approach for selecting communications channels based on performance
CA2570324C (en) * 2004-08-03 2014-07-22 Transtech Pharma, Inc. Rage fusion proteins and methods of use
US8849213B2 (en) * 2009-01-21 2014-09-30 Bandspeed, Inc. Integrated circuit for signal analysis
US8447252B2 (en) * 2009-01-21 2013-05-21 Bandspeed, Inc. Adaptive channel scanning for detection and classification of RF signals
BR112023024275A2 (pt) * 2021-05-20 2024-01-30 Artema Therapeutics Inc Variantes de kcnv2 e seu uso

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710019A (en) * 1995-06-05 1998-01-20 Human Genome Sciences, Inc. Human potassium channel 1 and 2 proteins
JPH09121865A (ja) * 1995-10-30 1997-05-13 Takeda Chem Ind Ltd 新規ｇ蛋白質共役型レセプター蛋白質、その製造法および用途
CA2238010A1 (en) * 1995-11-23 1997-05-29 Cancer Research Campaign Technology Limited Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
US5856155A (en) 1996-02-23 1999-01-05 The Johns Hopkins University School Of Medicine Compounds and related methods for modulating potassium ion channels and assays for such compounds
WO1998016185A2 (en) 1996-10-17 1998-04-23 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
NZ505252A (en) * 1997-12-19 2002-12-20 Upjohn Co Human sel-10 polypeptides and polynucleotides that encode them
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
WO2000009693A2 (en) * 1998-08-11 2000-02-24 Darwin Discovery Ltd. Identification of the gene causing the mouse scurfy phenotype and its human ortholog

Also Published As

Publication number Publication date
AU5348601A (en) 2001-10-30
US6727353B2 (en) 2004-04-27
WO2001079455A1 (en) 2001-10-25
US7528231B2 (en) 2009-05-05
US20040157261A1 (en) 2004-08-12
EP1183330A1 (de) 2002-03-06
CA2370572A1 (en) 2001-10-25
US20040053357A1 (en) 2004-03-18
EP1183330A4 (de) 2003-06-11
WO2001079455A9 (en) 2010-10-07
EP1183330B1 (de) 2011-05-25
AU780103B2 (en) 2005-03-03
JP2003530849A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
ATE419388T1 (de) Nukleinsäureanreicherung
ATE515702T1 (de) Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
DE50303413D1 (de) Befestigungsmittel und Verfahren zu seiner Herstellung
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
BR0009206A (pt) Isolamento e análise de proteina
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DE60126337D1 (de) Verfahren zum screenen für gpr40-liganden
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE510906T1 (de) Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
HK1088016A1 (en) Isolated fluorescent protein from clytia gregaria cgfp and use thereof
ATE316577T1 (de) Das goodpasture-antigen bindende protein
WO2004046293A8 (en) Amphoteric fluorescent whitening agents
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
ATE533779T1 (de) Isoliertes photoprotein mtclytin, sowie dessen verwendung
EP1179004A4 (de) Der kalium kanal kcnq5
ATE376058T1 (de) Kv6.2, eine potential-abhängige untereinheit des kaliumkanals.
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2002079479A3 (en) Motor proteins and methods for their use
WO2002040649A8 (en) Slo2 and slo4, novel potassium channel proteins from human brain
WO2003004678A3 (en) Novel receptors
ATE437650T1 (de) Tyrosinasemutante und verfahren zur verwendung davon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties